R. Toyoshima

Neutrophil‐to‐lymphocyte ratio is a potential prognostic biomarker for extramammary Paget disease: A retrospective study

K. Yoshino, T. Maeda, J. Uehara, 2022, The Journal of dermatology.

Early tumour response assessment may avoid serious immune‐related adverse events in nivolumab and ipilimumab combination therapy for stage IV melanoma

K. Yoshino, J. Uehara, A. Hiura, 2021, The British journal of dermatology.

Combined carboplatin and paclitaxel therapy improves overall survival in patients with nivolumab‐resistant acral and mucosal melanoma

K. Yoshino, J. Uehara, A. Hiura, 2021, The British journal of dermatology.

Real-world efficacy of nivolumab plus ipilimumab combination therapy versus nivolumab monotherapy for Stage IV melanoma patients in Asia

K. Yoshino, T. Maeda, J. Uehara, 2021, European Journal of Dermatology.

Sentinel lymph node biopsy in extramammary Paget disease: A 13‐year institutional experience

K. Yoshino, T. Maeda, J. Uehara, 2022, The Journal of dermatology.

Neutrophil-to-lymphocyte ratio is associated with survival and sentinel lymph node positivity in invasive cutaneous squamous cell carcinoma: A retrospective study.

K. Yoshino, T. Maeda, J. Uehara, 2021, Journal of the American Academy of Dermatology.